Riverview Trust Company’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-103
| Closed | -$19K | – | 652 |
|
|
2024
Q4 | $19K | Sell |
103
-3
| -3% | -$554 | 0.02% | 490 |
|
|
2024
Q3 | $20.9K | Buy |
106
+3
| +3% | +$591 | 0.02% | 452 |
|
|
2024
Q2 | $21.3K | Sell |
103
-265
| -72% | -$54.7K | 0.02% | 406 |
|
|
2024
Q1 | $99.7K | Buy |
+368
| New | +$99.7K | 0.08% | 169 |
|
|
2023
Q4 | – | Sell |
-265
| Closed | -$51.9K | – | 204 |
|
|
2023
Q3 | $51.9K | Hold |
265
| – | – | 0.05% | 228 |
|
|
2023
Q2 | $55.7K | Hold |
265
| – | – | 0.05% | 193 |
|
|
2023
Q1 | $53.5K | Hold |
265
| – | – | 0.05% | 202 |
|
|
2022
Q4 | $58K | Hold |
265
| – | – | 0.05% | 193 |
|
|
2022
Q3 | $52K | Hold |
265
| – | – | 0.05% | 198 |
|
|
2022
Q2 | $57K | Sell |
265
-69
| -21% | -$14.8K | 0.05% | 192 |
|
|
2022
Q1 | $95K | Buy |
334
+69
| +26% | +$19.6K | 0.07% | 153 |
|
|
2021
Q4 | $100 | Hold |
265
| – | – | 0.06% | 121 |
|
|
2021
Q3 | $109K | Hold |
265
| – | – | 0.12% | 113 |
|
|
2021
Q2 | $98K | Hold |
265
| – | – | 0.1% | 119 |
|
|
2021
Q1 | $77K | Hold |
265
| – | – | 0.09% | 127 |
|
|
2020
Q4 | $66K | Hold |
265
| – | – | 0.07% | 129 |
|
|
2020
Q3 | $60K | Hold |
265
| – | – | 0.07% | 133 |
|
|
2020
Q2 | $46K | Hold |
265
| – | – | 0.04% | 153 |
|
|
2020
Q1 | $33K | Hold |
265
| – | – | 0.03% | 166 |
|
|
2019
Q4 | $40K | Hold |
265
| – | – | 0.03% | 181 |
|
|
2019
Q3 | $35K | Hold |
265
| – | – | 0.02% | 187 |
|
|
2019
Q2 | $38K | Hold |
265
| – | – | 0.03% | 174 |
|
|
2019
Q1 | $38K | Hold |
265
| – | – | 0.03% | 174 |
|
|
2018
Q4 | $30K | Buy |
+265
| New | +$30K | 0.02% | 186 |
|